Delivery Order SPE2DB20D3103-SPE2DB23FN2P2
Award Date
5/2/23
Potential Completion Date
5/3/23
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a pharmaceutical product. The $13,607.57 delivery order contract has a performance period through May 7, 2024 and utilizes a firm fixed price pricing type. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a Delivery Order valued at $2,000.11 for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of November 8, 2023. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating the contract was awarded through full and open competition. Amerisourcebergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Micardis HCT 80-12.5 mg tablet units. The award, valued at $6,060.65, is a firm fixed-price delivery order contract with a completion date of March 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,301.18 for the supply of Micardis HCT 80-25 mg tablet medication. The award was made by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, and has an ultimate completion date of January 27, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) was issued by the Defense Logistics Agency (DLA) under contract number SPE2DB20D2104|SPE2DB22FS44Y. The $2,645.04 firm fixed-price delivery order is for the supply of Micardis HCT 40-12.5 mg tablets. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $6,183.14 firm fixed-price delivery order for the supply of MICARDIS HCT 80-12.5 MG TABLET UD 30S. The award, issued by the Defense Logistics Agency (DLA), has an ultimate completion date of November 23, 2021. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $3,113.28, is for the delivery of MICARDIS HCT 40-12.5 MG TABLET UD 30S to the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of June 26, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablet units to the Defense Logistics Agency (DLA). The $2,840.23 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has an ultimate completion date of November 17, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,345.87 delivery order contract is for the supply of MICARDIS HCT 80-12.5 MG TABLET UD 30S, a cardiovascular medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FP77M) valued at $4,476.62 for the supply of Micardis HCT 80-25 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...